Login / Signup

Patients With Coronary Microvascular Dysfunction Have Less Circulating α-Klotho.

Nadia AkhiyatIlke ÖzcanRajiv GulatiAbhiram PrasadTamara TchkoniaJames L KirklandBradley R LewisLilach Orly LermanAmir Lerman
Published in: Journal of the American Heart Association (2024)
Klotho may be a biomarker for CMD and may be a therapeutic target for groups of patients without significant traditional cardiovascular risk.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • coronary artery
  • prognostic factors
  • peritoneal dialysis
  • aortic stenosis
  • aortic valve